These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 26107781)

  • 1. Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution.
    Moravek MB; Bulun SE
    Curr Opin Obstet Gynecol; 2015 Aug; 27(4):276-83. PubMed ID: 26107781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MED12 exon 2 mutations in histopathological uterine leiomyoma variants.
    Mäkinen N; Vahteristo P; Kämpjärvi K; Arola J; Bützow R; Aaltonen LA
    Eur J Hum Genet; 2013 Nov; 21(11):1300-3. PubMed ID: 23443020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
    Commandeur AE; Styer AK; Teixeira JM
    Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MED12 mutations in uterine fibroids--their relationship to cytogenetic subgroups.
    Markowski DN; Bartnitzke S; Löning T; Drieschner N; Helmke BM; Bullerdiek J
    Int J Cancer; 2012 Oct; 131(7):1528-36. PubMed ID: 22223266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine fibroids: do we deal with more than one disease?
    Markowski DN; Helmke BM; Bartnitzke S; Löning T; Bullerdiek J
    Int J Gynecol Pathol; 2014 Nov; 33(6):568-72. PubMed ID: 25272295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Place of ulipristal acetate in the management of uterine fibroids: Preoperative treatment or sequential treatment?
    Pourcelot AG; Capmas P; Fernandez H
    J Gynecol Obstet Hum Reprod; 2017 Mar; 46(3):249-254. PubMed ID: 28403922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ulipristal acetate for uterine fibroid-related symptoms.
    Puchar A; Luton D; Koskas M
    Drugs Today (Barc); 2015 Nov; 51(11):661-7. PubMed ID: 26744741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate.
    Kolterud Å; Välimäki N; Kuisma H; Patomo J; Ilves ST; Mäkinen N; Kaukomaa J; Palin K; Kaasinen E; Karhu A; Pasanen A; Bützow R; Heikinheimo O; Kopp Kallner H; Aaltonen LA
    Hum Mol Genet; 2023 Mar; 32(7):1063-1071. PubMed ID: 36048862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular matrix (ECM) activates β-catenin signaling in uterine fibroids.
    Ko YA; Jamaluddin MFB; Adebayo M; Bajwa P; Scott RJ; Dharmarajan AM; Nahar P; Tanwar PS
    Reproduction; 2018 Jan; 155(1):61-71. PubMed ID: 29066531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction: Are we advancing in our scientific understanding and therapeutic improvement of uterine fibroids… or not?
    Simón C
    Fertil Steril; 2014 Sep; 102(3):611-2. PubMed ID: 25171949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids.
    Halder SK; Laknaur A; Miller J; Layman LC; Diamond M; Al-Hendy A
    Mol Genet Genomics; 2015 Apr; 290(2):505-11. PubMed ID: 25325994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging treatment options for uterine fibroids.
    Donnez J; Arriagada P; Donnez O; Dolmans MM
    Expert Opin Emerg Drugs; 2018 Mar; 23(1):17-23. PubMed ID: 29486606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenomic and enhancer dysregulation in uterine leiomyomas.
    Mlodawska OW; Saini P; Parker JB; Wei JJ; Bulun SE; Simon MA; Chakravarti D
    Hum Reprod Update; 2022 Jun; 28(4):518-547. PubMed ID: 35199155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate.
    Donnez J; Donnez O; Dolmans MM
    Expert Opin Drug Saf; 2016 Dec; 15(12):1679-1686. PubMed ID: 27740868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulipristal acetate in the management of symptomatic uterine fibroids: facts and pending issues.
    Pérez-López FR
    Climacteric; 2015 Apr; 18(2):177-81. PubMed ID: 25390187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MED12 mutation frequency in unselected sporadic uterine leiomyomas.
    Heinonen HR; Sarvilinna NS; Sjöberg J; Kämpjärvi K; Pitkänen E; Vahteristo P; Mäkinen N; Aaltonen LA
    Fertil Steril; 2014 Oct; 102(4):1137-42. PubMed ID: 25108465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ulipristal acetate for use in moderate to severe symptoms of uterine fibroids.
    Talaulikar VS; Manyonda I
    Womens Health (Lond); 2014 Nov; 10(6):565-70. PubMed ID: 25482483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Ulipristal Acetate for the Management of Fibroid-Related Acute Abnormal Uterine Bleeding.
    Arendas K; Leyland NA
    J Obstet Gynaecol Can; 2016 Jan; 38(1):80-3. PubMed ID: 26872761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RISING STARS: Role of MED12 mutation in the pathogenesis of uterine fibroids.
    Ishikawa H; Kobayashi T; Kaneko M; Saito Y; Shozu M; Koga K
    J Mol Endocrinol; 2023 Nov; 71(4):. PubMed ID: 37668348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A-Kinase Anchoring Protein 13 (AKAP13) Augments Progesterone Signaling in Uterine Fibroid Cells.
    Ng SSM; Jorge S; Malik M; Britten J; Su SC; Armstrong CR; Brennan JT; Chang S; Baig KM; Driggers PH; Segars JH
    J Clin Endocrinol Metab; 2019 Mar; 104(3):970-980. PubMed ID: 30239831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.